Vaccines of the future

@article{Smith2003VaccinesOT,
  title={Vaccines of the future},
  author={Richard Thomas Smith and Ronald C. Renaud},
  journal={Nature Reviews Drug Discovery},
  year={2003},
  volume={2},
  pages={767-768}
}
Key PointsThis report has been prepared by Bear, Stearns & Co. Inc., Bear, Stearns International Limited or Bear Stearns Asia Limited (together with their affiliates, 'Bear Stearns'), as indicated on the cover page hereof. This report has been adopted and approved for distribution in the United States by Bear, Stearns & Co. Inc. If you are a recipient of this publication in the United States, orders in any securities referred to herein should be placed with Bear, Stearns & Co. Inc. This report… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-2 OF 2 CITATIONS

Alzheimer ’ s disease at the cross-roads

Almeida OF Spedding M. Agid Y, Benveniste O Amouyel P, Bohr Blennow K
  • 2013

References

Publications referenced by this paper.
SHOWING 1-4 OF 4 REFERENCES

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

C Drosten
  • N. Engl. J. Med
  • 2003

lessons learned from the World’s first phase III efficacy trials

Francis, D. et al. Candidate HIVAIDS vaccines
  • AIDS 17, 147–156
  • 2003